AKT1 and neoplasm: In tumor cells, LDHC contributes to metabolic reprogramming by driving aerobic glycolysis and promotes tumor cell invasion, migration, and proliferation through activation of the PI3K/Akt/GSK-3B signaling pathway [13, 14].